For COVID-19 vaccine updates, please review our information guide and sign up for Connect. Continue your routine care with us by scheduling an in-person appointment or Video Visit.
The availability of new monoclonal antibodies and novel targeted therapies for chronic lymphocytic leukemia has greatly increased the complexity of treating symptomatic patients. Richard Furman, M.D. joins a panel of doctors and researchers in this OncLive video.